Found: 10
Select item for more details and to access through your institution.
Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
- Published in:
- Heart & Vessels, 2019, v. 34, n. 4, p. 698, doi. 10.1007/s00380-018-1286-2
- By:
- Publication type:
- Article
Mental distress and health‐related quality of life among type 1 and type 2 diabetes patients using self‐monitoring of blood glucose: A cross‐sectional questionnaire study in Japan.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 5, p. 1203, doi. 10.1111/jdi.12827
- By:
- Publication type:
- Article
NHIBITORY EFFECT OF PIOGLITAZONE ON CAROTID ARTERIAL WALL THICKNESS IN TYPE 2 DIABETES.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 7, p. 3452, doi. 10.1210/jcem.86.7.7810
- By:
- Publication type:
- Article
Lack of effect of pioglitazone on postprandial triglyceride levels in type 2 diabetes.
- Published in:
- 2001
- By:
- Publication type:
- research
Improvement of Glycemic Control After Treatment With Mosapride for Diabetic Gastropathy.
- Published in:
- Diabetes Care, 2000, v. 23, n. 8, p. 1198, doi. 10.2337/diacare.23.8.1198
- By:
- Publication type:
- Article
Treatment Burden on Once-Weekly Omarigliptin Versus Daily Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes: Randomized Controlled Trial (ONWARD-DPP4 Study).
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 10, p. 1639, doi. 10.1007/s13300-023-01442-0
- By:
- Publication type:
- Article
Comparison of Patient-Led and Physician-Led Insulin Titration in Japanese Type 2 Diabetes Mellitus Patients Based on Treatment Distress, Satisfaction, and Self-Efficacy: The COMMIT-Patient Study.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 595, doi. 10.1007/s13300-020-00995-8
- By:
- Publication type:
- Article
Quality-of-Life Comparison of Dapagliflozin Versus Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (J-BOND Study).
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 12, p. 2959, doi. 10.1007/s13300-020-00941-8
- By:
- Publication type:
- Article
Efficacy and safety of sodium--glucose cotransporter 2 inhibitor ipragliflozin on glycemic control and cardiovascular parameters in Japanese patients with type 2 diabetes mellitus; Fukuoka Study of Ipragliflozin (FUSION).
- Published in:
- Endocrine Journal, 2018, v. 65, n. 8, p. 859, doi. 10.1507/endocrj.ej18-0022
- By:
- Publication type:
- Article